Found: 35
Select item for more details and to access through your institution.
Complementarity of Blue Dye and Isotope in Sentinel Node Localization for Breast Cancer: Univariate and Multivariate Analysis of 966 Procedures.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2001, v. 8, n. 1, p. 13, doi. 10.1007/s10434-001-0013-9
- By:
- Publication type:
- Article
Molecular Imaging of Neuroendocrine Differentiation of Prostate Cancer: A Case Series.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
The role of <sup>18</sup>F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!
- Published in:
- 2019
- By:
- Publication type:
- journal article
Nodal metabolic tumour volume on baseline <sup>18</sup>F‐FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative‐intent chemoradiotherapy/radiotherapy.
- Published in:
- Journal of Medical Imaging & Radiation Oncology, 2021, v. 65, n. 6, p. 748, doi. 10.1111/1754-9485.13294
- By:
- Publication type:
- Article
Does addition of a diagnostic contrast-enhanced CT to a contemporaneous PET/CT provide incremental value in patients for restaging of colorectal carcinoma?
- Published in:
- European Journal of Hybrid Imaging, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41824-018-0046-y
- By:
- Publication type:
- Article
The Victorian Comprehensive Cancer Centre lung cancer clinical audit: collecting the UK National Lung Cancer Audit data from hospitals in Australia.
- Published in:
- Internal Medicine Journal, 2019, v. 49, n. 8, p. 1001, doi. 10.1111/imj.14183
- By:
- Publication type:
- Article
Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol.
- Published in:
- Thyroid, 2019, v. 29, n. 11, p. 1634, doi. 10.1089/thy.2019.0143
- By:
- Publication type:
- Article
High clinical and morphologic response using Y-DOTA-octreotate sequenced with Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 3, p. 476, doi. 10.1007/s00259-016-3527-x
- By:
- Publication type:
- Article
Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedside.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 1, p. 25, doi. 10.1007/s00259-014-2888-2
- By:
- Publication type:
- Article
Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living rats.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 9, p. 1281, doi. 10.1007/s00259-003-1143-z
- By:
- Publication type:
- Article
Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 4, p. 588, doi. 10.1007/s00259-002-1097-6
- By:
- Publication type:
- Article
Efficacy and safety of 177Lu-DOTATATE in lung neuroendocrine tumors: a bi-center study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.260760
- By:
- Publication type:
- Article
Efficacy and safety of <sup>177</sup>Lu-DOTATATE in lung neuroendocrine tumors: a bi-center study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.260760
- By:
- Publication type:
- Article
Efficacy and safety of <sup>177</sup>Lu-DOTATATE in lung neuroendocrine tumors: a bi-center study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.260760
- By:
- Publication type:
- Article
Efficacy and safety of <sup>177</sup>Lu-DOTATATE in lung neuroendocrine tumors: a bi-center study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.260760
- By:
- Publication type:
- Article
Efficacy and safety of <sup>177</sup>Lu-DOTATATE in lung neuroendocrine tumors: a bi-center study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.260760
- By:
- Publication type:
- Article
Efficacy and safety of <sup>177</sup>Lu-DOTATATE in lung neuroendocrine tumors: a bi-center study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.260760
- By:
- Publication type:
- Article
Long term follow-up and outcomes of re-treatment in an expanded 50 patient single-center phase II prospective trial of Lutetium-177 (177Lu) PSMA-617 theranostics in metastatic castrate-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236414
- By:
- Publication type:
- Article
Dosimetry of <sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 4, p. 517, doi. 10.2967/jnumed.118.219352
- By:
- Publication type:
- Article
What <sup>18</sup>F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 328, doi. 10.2967/jnumed.118.214148
- By:
- Publication type:
- Article
PET/CT Colonography.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 9, p. 1489, doi. 10.2967/jnumed.110.079632
- By:
- Publication type:
- Article
SUV<sub>fdg</sub>: A standard-uptake-value (SUV) body habitus normalizer specific to fluorodeoxyglucose (FDG) in humans.
- Published in:
- PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0266704
- By:
- Publication type:
- Article
The Role of 68Ga-DOTA-Octreotate PET/CT in Follow-Up of SDH-Associated Pheochromocytoma and Paraganglioma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 13, p. 3970, doi. 10.1007/s00259-023-06371-5
- By:
- Publication type:
- Article
Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 1, p. 204, doi. 10.1007/s00259-020-04915-7
- By:
- Publication type:
- Article
FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 12, p. 2776, doi. 10.1007/s00259-020-04815-w
- By:
- Publication type:
- Article
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 10, p. 2322, doi. 10.1007/s00259-020-04723-z
- By:
- Publication type:
- Article
Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1902, doi. 10.1007/s00259-019-04389-2
- By:
- Publication type:
- Article
PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessment.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1869, doi. 10.1007/s00259-019-04388-3
- By:
- Publication type:
- Article
Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 3, p. 718, doi. 10.1007/s00259-018-4196-8
- By:
- Publication type:
- Article
Limitations of CT During PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 10, p. 1583, doi. 10.2967/jnumed.107.043109
- By:
- Publication type:
- Article
Combined <sup>18</sup>F-FDG and <sup>11</sup>C-Methionine PET Scans in Patients with Newly Progressive Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2002, v. 43, n. 1, p. 46
- By:
- Publication type:
- Article
Hybrid PET/CT Machines: Optimized PET Machines for the New Millennium?
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 5, p. 961
- By:
- Publication type:
- Article
Abnormal Colonic Accumulation of Fluorine-18-FDG in Pseudomembranous Colitis.
- Published in:
- Journal of Nuclear Medicine, 1996, v. 37, n. 10, p. 1683
- By:
- Publication type:
- Article